AMGN : NASDAQ
Industry: Biotechnology

Balance Sheet
2008
12/31/08
2007
12/31/07
2006
12/31/06
2005
12/31/05
Cash1,7742,0241,2831,840
Short Term Investments7,7785,1274,9943,415
ASSETS
Cash & Short Term Investments9,5527,1516,2775,255
Receivables - Net2,0732,1012,1241,769
Raw Materials112173205145
Work in Progress1,5191,2461,090758
Finished Goods444672608355
Inventories - Total2,0752,0911,9031,258
Prepaid Expenses--------
Other Current Assets1,5211,6981,408953
CURRENT ASSETS - TOTAL15,22113,04111,7129,235
Land456451398294
Buildings3,2053,1022,7762,485
Machinery & Equipment2,3542,0521,8421,541
Other Property, Plant & Equipment3,1543,0032,4012,043
Property, Plant and Equipment - Gross9,9959,5018,6887,321
Accumulated Depreciation(4,116)(3,560)(2,767)(2,283)
Property, Plant and Equipment - Net5,8795,9415,9215,038
Investments in Associated Companies356292241180
Other Investments30305683
Other Tangible Assets630763809524
Total Intangible Other Assets - Net14,32714,57215,04914,237
Other Assets - Total14,95715,33515,85814,761
TOTAL ASSETS36,44334,63933,78829,297
LIABILITIES
Accounts Payable504378555596
Short Term Debt & Current Portion of Long Term Debt1,0002,0001,8780
Accrued Payroll1,6751,9522,1471,601
Income Taxes Payable--1911,057476
Other Current Liabilities1,7071,6581,385922
CURRENT LIABILITIES - TOTAL4,8866,1797,0223,595
Long Term Debt9,1769,1777,1343,957
Deferred Taxes - Credit--4803671,163
DEFERRED TAXES--4803671,163
Other Liabilities1,995934301131
TOTAL LIABILITIES16,05716,77014,8248,846
EQUITY
Non-Equity Reserves--000
Minority Interest0000
Preferred Stock0000
Common Stock100K100K100K100K
Capital Surplus25,52724,97624,15523,561
Unappropriated (Free) Reserves64------
Retained Earnings(5,258)(7,160)(5,203)(3,132)
Unrealized Foreign Exchange Gain/Loss1416456
Unrealized Gain/Loss on Marketable Securities3937(33)16
COMMON EQUITY20,38617,86918,96420,451
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY36,44334,63933,78829,297
SHARE INFORMATION
Common Shares Outstanding1,0471,0871,1661,224
2009 Q3
9/30/09
2009 Q2
6/30/09
2009 Q1
3/31/09
2008 Q4
12/30/08
2008 Q3
9/30/08
Cash------1,774--
ASSETS
Cash & Short Term Investments14,01311,96510,3789,5529,757
Receivables - Net2,3312,1822,0102,0732,114
Inventories - Total2,1552,0612,0802,0752,004
Prepaid Expenses----------
Other Current Assets1,4751,4881,6081,5211,745
CURRENT ASSETS - TOTAL19,97417,69616,07615,22115,620
Property, Plant and Equipment - Gross10,24310,20010,1049,9959,972
Accumulated Depreciation(4,500)(4,400)(4,300)(4,116)(4,000)
Property, Plant and Equipment - Net5,7435,8005,8045,8795,972
Investments in Associated Companies0003560
Total Intangible Other Assets - Net14,00914,11914,21814,32714,435
Other Assets - Total15,22315,34415,50014,98715,406
TOTAL ASSETS40,94038,84037,38036,44336,998
LIABILITIES
Accounts Payable613635687504538
Short Term Debt & Current Portion of Long Term Debt1,0001,0001,0001,0001,000
Other Current Liabilities3,2902,9132,9863,3823,413
CURRENT LIABILITIES - TOTAL4,9034,5484,6734,8864,951
Long Term Debt10,53610,47110,4089,17610,176
Deferred Taxes - Credit--------346
DEFERRED TAXES000--346
Other Liabilities2,6432,4612,3321,9951,693
TOTAL LIABILITIES18,08217,48017,41316,05717,166
EQUITY
Non-Equity Reserves000--0
Minority Interest000--0
Preferred Stock000--0
Common Stock100K100K100K100K100K
Capital Surplus26,85326,72026,52625,52725,348
Retained Earnings(4,042)(5,423)(6,659)(5,258)(5,519)
Unrealized Foreign Exchange Gain/Loss------14--
Unrealized Gain/Loss on Marketable Securities------39--
COMMON EQUITY22,85821,36019,96720,38619,832
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY40,94038,84037,38036,44336,998
SHARE INFORMATION
Common Shares Outstanding1,0161,0151,0111,0471,059
() = Negative Values
Values are displayed in Millions except for earnings per share and where noted